Clinical Scorecard: Flu Cases in the U.S. Experience Minor Decrease, Yet Severe Season Continues
At a Glance
Category
Detail
Condition
Seasonal influenza with predominance of A H3N2 subtype
Key Mechanisms
Circulation of a new H3N2 subclade K variant differing from vaccine strain
Target Population
General U.S. population, with increased risk in older adults and children
Care Setting
Outpatient clinics, hospitals, and public health surveillance
Key Highlights
Slight decline in flu-like illness visits and states reporting high flu activity, but overall severe season continues.
Predominance of A H3N2 virus, with over 91% infections caused by a new subclade K variant not well matched by current vaccines.
High burden with estimated 15 million illnesses, 180,000 hospitalizations, and 7,400 deaths including at least 17 children this season.
Guideline-Based Recommendations
Diagnosis
Monitor flu-like illness visits and hospitalizations to assess flu activity trends.
Consider testing for influenza, especially in high-risk populations during peak season.
Management
Annual influenza vaccination recommended for individuals 6 months and older, though recent federal guidance advises individualized decision-making for children.
Use antiviral treatments as appropriate to reduce severity and complications.
Monitoring & Follow-up
Track state-level flu activity and hospitalization rates to identify surges or declines.
Monitor circulating influenza virus strains to inform vaccine strain selection and public health responses.
Risks
Older adults and children are at higher risk for severe illness and hospitalization, especially with A H3N2 infections.
New virus variants may reduce vaccine effectiveness, increasing risk of severe outcomes.
Potential for multiple surges within a single flu season complicates prediction and response.
Patient & Prescribing Data
U.S. population including children, adults, and elderly during the 2023-2024 flu season
Vaccination remains a key preventive measure, though vaccine mismatch with circulating strains may reduce effectiveness; antiviral therapy is important for managing severe cases.
Clinical Best Practices
Encourage influenza vaccination for all eligible individuals, emphasizing consultation for pediatric vaccination decisions.
Maintain vigilance for flu activity changes, especially during holidays and travel periods.
Educate patients on recognizing flu symptoms and seeking timely medical care to reduce complications.
Coordinate surveillance data with clinical management to adapt to evolving virus variants.
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
